Pfaar O.Klimek L.Jutel M.Akdis C.Bousquet J.Akdis M.Bachert C.Agache I.Ansotegui I.Bedbrook A.Bosnic-Anticevich S.Canonica G.W.Chivato T.Cruz A.A.Czarlewski W.Del Giacco S.Du H.Fonseca J.A.Gao Y.Haahtela T.Hoffmann-Sommergruber K.Ivancevich J.-C.Khaltaev N.Knol E.F.Kuna P.Larenas-Linnemann D.Melen E.Mullol J.Naclerio R.Ohta K.Okamoto Y.O’Mahony L.Onorato G.L.Papadopoulos N.G.Pawankar R.Samolinski B.Schwarze J.Toppila-Salmi S.Shamji M.H.Teresa Ventura M.Valiulis A.Yorgancioglu A.Matricardi P.Zuberbier T.2024-07-222024-07-22202001054538http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13880[No abstract available]EnglishAll Open Access; Bronze Open AccessAllergistsAsthmaBetacoronavirusCD8-Positive T-LymphocytesCoronavirus InfectionsEosinophilsHumansImmunoglobulin EImmunoglobulin MInfection ControlPandemicsPneumonia, ViralRhinitis, AllergicSublingual ImmunotherapyTh2 Cellsallergenimmunoglobulin Eimmunoglobulin MArticlecoronavirus disease 2019desensitizationhumanimmunological toleranceimmunologistpandemicpractice guidelinepriority journalrisk assessmentSevere acute respiratory syndrome coronavirus 2allergic rhinitisasthmaBetacoronavirusCD8+ T lymphocytecomplicationCoronavirus infectioneosinophilgeneticsimmunologyinfection controlmetabolismpandemicprocedurespsychologysublingual immunotherapyTh2 cellvirologyvirus pneumoniaArticle10.1111/all.14336